Roivant Sciences Ltd Q4 2024 Earnings Call Summary - Thomson StreetEvents

Roivant Sciences Ltd Q4 2024 Earnings Call Summary

Roivant Sciences Ltd Q4 2024 Earnings Call Summary - Thomson StreetEvents
Roivant Sciences Ltd Q4 2024 Earnings Call Summary
Published May 29, 2025
14 pages (7143 words) — Published May 29, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of ROIV.OQ earnings conference call or presentation 29-May-25 12:00pm GMT

  
Brief Excerpt:

...A. First with brepocitinib, which obviously has the potential to be an on-market therapy as soon as within the next couple of years with this data coming in dermatomyositis. B. With IMVT-1402 actively enrolling multiple potentially registrational studies across or pivotal studies across multiple indications, where we either already know or strongly expect FcRn antibodies to matter quite a lot. C. We also have mostly mosliciguat, our inhale therapy for PH-ILD with data expected to be coming next year....

  
Report Type:

Brief

Source:
Company:
Roivant Sciences Ltd
Ticker
ROIV.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Roivant Sciences Ltd at Goldman Sachs Global Healthcare Conference Summary – 2025-06-10 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 10-Jun-25 11:00pm GMT

Roivant Sciences Ltd at Goldman Sachs Global Healthcare Conference Transcript – 2025-06-10 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 10-Jun-25 11:00pm GMT

Roivant Sciences Ltd at Jefferies Global Healthcare Conference Summary – 2025-06-05 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 5-Jun-25 11:20pm GMT

Roivant Sciences Ltd at Jefferies Global Healthcare Conference Transcript – 2025-06-05 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 5-Jun-25 11:20pm GMT

Roivant Sciences Ltd Q4 2024 Earnings Call Transcript – 2025-05-29 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 29-May-25 12:00pm GMT

Roivant Sciences Ltd at Bank of America Global Healthcare Conference Summary – 2025-05-14 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 14-May-25 11:20pm GMT

Roivant Sciences Ltd at Bank of America Global Healthcare Conference Transcript – 2025-05-14 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 14-May-25 11:20pm GMT

Roivant Sciences Ltd Investor Call Summary – 2025-04-21 – US$ 54.00 – Edited Brief of ROIV.OQ corporate analyst meeting</ 21-Apr-25 12:00pm GMT

Roivant Sciences Ltd Investor Call Transcript – 2025-04-21 – US$ 54.00 – Edited Transcript of ROIV.OQ corporate analyst meeting</ 21-Apr-25 12:00pm GMT

Roivant Sciences Ltd at TD Cowen Healthcare Conference Summary – 2025-03-04 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 4-Mar-25 6:10pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roivant Sciences Ltd Q4 2024 Earnings Call Summary" May 29, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2024-Roivant-Sciences-Ltd-Earnings-Call-B16379422>
  
APA:
Thomson StreetEvents. (2025). Roivant Sciences Ltd Q4 2024 Earnings Call Summary May 29, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2024-Roivant-Sciences-Ltd-Earnings-Call-B16379422>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.